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Received 27 January 2004; accepted 11 February 2004Abstract—Stereoisomerically pure 3b-hydroxy-5,6-epoxysteroids were obtained by combining selective chemical methods for a- and
b-epoxidation of D5-unsaturated steroids with enzymatic stereoselective esterification of the 3b-hydroxyl group. 5b,6b-Epoxy-3b-
hydroxysteroids were efficiently acylated by Novozym 435 and lipase AK, whereas 5a,6a-epoxy-3b-hydroxysteroids were good
substrates for Candida rugosa lipase. Mild enzymatic deacylation of the 3b-acetoxy group in the presence of the epoxy functionality
was also accomplished by C. rugosa lipase-mediated hydrolysis.
 2004 Elsevier Ltd. All rights reserved.1. Introduction
Steroid epoxides are an important group of oxysterols,
which regulate many biological functions, such as cell
proliferation and cholesterol homeostasis.1 For instance,
a- and b-epoxides of cholesterol are bioactive autoxi-
dation products,1;2 both being cytotoxic3 and muta-
genic,4 while the 5b,6b-epoxy functionality is found in a
number of naturally occurring steroids possessing anti-
tumour activities, such as the withanolides.5 Further-
more, epoxides are synthetically valuable intermediates,
since their facile ring opening allows the introduction of
various functionalities in a stereospecific manner.6 These
properties have attracted considerable attention for the
stereoselective synthesis of 5a,6a-epoxides (a-epoxides)
and 5b,6b-epoxides (b-epoxides) on the steroid nucleus.
Epoxidation of 3b-substituted D5-steroids with perac-
ids,7 such as 3-chloroperoxybenzoic acid (m-CPBA), is
known to produce predominantly a-epoxides due to the
steric hindrance imposed by the C-10 and C-13 angular
methyl groups. Current methods for the synthesis of
b-epoxides include the use of halohydrins as intermedi-
ates,8 the use of 3-halo substituents to block the entry of
reagents from the alpha face,9 chromyl diacetate,10
potassium permanganate/inorganic salts,11 chiral* Corresponding author. Tel.: +351-239-859990; fax: +351-239-8270-
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doi:10.1016/j.tetasy.2004.02.010ketones/oxone12 and transition metal complexes in the
presence of air or molecular oxygen as oxidant.13
However, the majority of these methods fail to give
diastereomerically pure a- and b-epoxides, thus more
selective methods are still needed. Furthermore, the
presence and stereochemistry of other substituents in the
A- and B-rings can influence the stereoselectivity of
the epoxidation method.11a;13b;14
Generally the methods used to prepare b-epoxides
require the appropriate protection of other hydroxyl
groups present on the molecule. Chemical deprotection,
quite often of an ester, can be hampered by the sensi-
tivity of the oxirane group towards the usual hydrolytic
conditions. As a consequence, the synthesis of 5b,6b-
epoxy-hydroxysteroids remains a difficult task.
Recently, biocatalysis, often being complementary to
conventional chemical reactions, has become an effective
tool for achieving mild and selective transformations.15
In particular, enzyme catalysis has played an important
role for the selective interconversion of functional
groups on the steroid structure.16;17 For example, studies
on the enzymatic regioselective esterification of hydroxyl
groups located at different positions of the skeleton have
shown a preference of lipases for OHs at the C-3 posi-
tion and of the protease subtilisin Carlsberg for the
hydroxyl groups on the D ring.18 Moreover, the influ-
ence of the A/B rings junction (cis or trans) and of D4- or
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3-hydroxy steroids has also been demonstrated.18;19
In order to provide diastereomerically pure a- or b-ep-
oxysteroids by taking advantage of the known selectivity
of enzymes towards steroidal substrates, we investigated
the ability of lipases to discriminate between such
epoxides through the acylation or deacylation of a
hydroxyl moiety at the 3b-position. Additionally, the
mild reaction conditions, provided by enzyme catalysis,
were explored for the hydrolysis of 3b-acetoxy esters in
the presence of the epoxy functionality.2. Results and discussion
2.1. Chemical synthesis of epoxides
a-Selective epoxidations of both 3b-hydroxy- and
3b-acetoxy-D5-unsaturated stereoids were performed
with magnesium monoperoxyphthalate hexahydrate
(MMPP), which is safer and easier to remove than
common peracids, like m-CPBA.20 Furthermore,
b-selective epoxidation of 3b-acetoxy-D5-unsaturated
steroids can be carried out through the low cost and eco-
friendly11 heterogeneous permanganate oxidation, fol-
lowing a procedure developed by our group.11b The a=b
ratio of epoxides was determined by the integration of
the H-6 proton signal in the 1H NMR spectra, which is
known to appear as a doublet at around 2.9 ppm
(J ¼ 4Hz) in the a isomer and as a doublet at 3.1 ppm
(J ¼ 2Hz) in the b isomer.21;13a As expected, the dia-
stereomeric excesses ranged between 70% and 80%.2.2. Stereoselective lipase-catalysed esterification of 3b-
hydroxy-5,6-epoxysteroids to produce diastereomerically
pure a-epoxides
The lipase-catalysed esterification of a 3b-hydroxy
group in the presence of a 5,6-epoxy functionality was
studied by screening the performances of a range of 14
commercial hydrolases using diastereomerically en-
riched 5,6-epoxycholestan-3b-ol 1 (a=b ratio 83:17) and
5,6-epoxy-3b-hydroxypregnan-20-one 2 (a=b ratioScheme 1. Novozym 435-catalysed stereoselective acetylation of 3b-hydroxy-
3b-acetoxy-5,6-epoxysteroids.90:10) as substrates (Scheme 1, left side). Under irre-
versible transesterification22 conditions (using vinyl
acetate as the acyl donor and toluene as the solvent),
TLC monitoring allowed the identification of a small
group of lipases active on these substrates. Almost
complete conversion of 1 was observed with Candida
rugosa lipase, suggesting a good activity of this enzyme
for the predominant a-isomer, whereas minor conver-
sion was noticed with Novozym 435, Chromobacterium
viscosum lipase, lipase AK and lipase PS. Later on, the
stereoselectivity of this group of lipases was more
accurately measured by monitoring the acylation of the
diastereomerically pure a-epoxide 1a and b-epoxide 1b
of cholesterol (obtained as described below) by GC. As
shown in Table 1, the stereopreference of Novozym 435
for the acylation of the 3b-OH of the b-epoxide 1b was
very high, while two different commercial preparations
of C. rugosa lipase confirmed a significant preference for
the a-epoxy isomer 1a (first two entries of Table 1).
By exploiting these results, Novozym 435 was employed
in preparative scale reactions to remove the minor
b-isomer in a-enriched mixtures of 3b-hydroxy-5,6-ep-
oxysteroids (Scheme 1, left hand side). In all cases, the
unreacted a-epoxides, 1a, 2a and 3a, were obtained in
good isolated yields (67–72%) and 100% diastereomeric
excesses, as confirmed by 1H NMR analysis.2.3. Stereoselective lipase-catalysed deacetylation of 3b-
acetoxy-5,6-epoxysteroids to produce diastereomerically
pure b-epoxides
The next step was to find a suitable methodology for
obtaining the complementary pure b-epoxides from the
b-enriched mixtures of the corresponding acetates 4–6
prepared through permanganate epoxidation.11b Ini-
tially the stereoselective deacetylation of epimeric
3b-acetoxy-5,6-epoxysteroids was investigated using
1-octanol as an acyl acceptor in alcoholysis reactions
(Scheme 1, right hand side). Exploiting the stereopre-
ference of C. rugosa lipase for a-epoxides (Table 1, lines
1–2), preparative scale reactions were run in the presence
of lipase AY in order to remove the minor a-epoxide in
mixtures 4–6. As expected, the unreacted 3-O-acetoxy
b-epoxides (10b, 20b and 30b) were obtained in good5,6-epoxysteroids and lipase AY-catalysed stereoselective alcoholysis of
Table 1. Lipase-catalysed acetylation of 1a and 1b
Conversion (%)a
Substrateb 90min 3 h 6 h 24 h
C. rugosa lipase (Sigma) 3mg 1a 62.3 84.8 86.5 96.4
1b 3.9 6.5 9.8 12.7
Lipase AYc (Amano) 1.5mg 1a 80.8 90.5 92 96.3
1b 2.5 6.3 7.8 9.8
Novozym 435d 10mg 1a 0 0 0 1
1b 14.3 26.4 47.9 82.3
Lipase PSe (Amano) 5mg 1a 10.2 23.7 33 71.4
1b 13.7 27.9 50 88.2
Lipase AKf (Amano) 3mg 1a 1.7 2.4 4.3 11.9
1b 15.2 29.6 53.1 90.6
C. viscosum lipase (Finnsugar) 30mg 1a 0 0 0 4.6
1b 4.5 9.6 16.7 41.7
a Evaluated by GC.
b 10mM 5a,6a- or 5b,6b-Epoxycholestan-3b-ol, 1a or 1b, (4mg/ml) in toluene with 10% v/v vinyl acetate.
c From C. rugosa.
d From C. antarctica.
e From P. cepacia.
f From P. fluorescens.
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cess, as confirmed by 1H NMR analysis. On the other
hand, quite unexpectedly, neither Novozym 435 nor any
other tested lipases were able to catalyse the selective
alcoholysis of the 3b-acetoxy group of b-epoxides.2.4. Mild nonselective lipase-catalysed deacetylation of
3b-acetoxy-5,6-epoxysteroid mixtures
As a final step, we searched for reaction conditions able
to promote a nonselective enzymatic alcoholysis, or
hydrolysis, of the 3b-acetoxy group in epimeric 5,6-ep-
oxysteroid mixtures (i.e., to transform 4–6 into 7–9). In
fact, a mild deacylation protocol is of synthetic value
since most of the methods used to prepare 5b,6b-epox-
ides are only applicable to 3-O-acylated substrates, and
the subsequent chemical deacylation by standard pro-
cedures usually affect also the sensitive epoxy groups.
The lack of selectivity shown by lipase PS in the acyl-
ation of these substrates (Table 1) suggested that this
lipase might be the enzyme of choice to accomplish the
requested mild deacylation reaction. Unfortunately, this
lipase did not accept 3b-acetoxy epoxysteroids as sub-
strates in alcoholysis under hydrolysis reactions.Scheme 2. C. rugosa lipase-catalysed mild deacylation of 3b-acetoxy-5,6-epoTherefore, we turned our attention again to C. rugosa
lipase, as this enzyme showed a minor activity towards
the b-epoxide epimers (Table 1). Careful optimisation of
the reaction conditions indicated that water-saturated
diisopropyl ether (DIPE) was the optimal system for
performing the required deacylation in the presence of
both a- and b-5,6-epoxides. Accordingly, scale-up
reactions allowed complete enzymatic hydrolysis of the
3b-acetate in the epimeric mixtures 4–6 without affecting
the sensitive epoxides to give the corresponding alcohols
7–9 (Scheme 2).
The b-enriched mixture of 5,6-epoxides of cholesterol 7
thus obtained was submitted to AY-catalysed stereo-
selective acylation in order to remove the minor
a-epoxide, rendering diastereomerically pure 5b,6b-ep-
oxycholestan-3b-ol 1b (Scheme 3), which was used to
study the stereoselectivity of lipases to 1a and 1b by GC
analysis (Table 1).3. Conclusion
Herein we have reported the further usefulness of lipases
for the selective modification of steroids. Specifically,xysteroids.
Scheme 3. Lipase AY-catalysed stereoselective acetylation of 5,6-epoxycholestane-3b-ol 7.
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exploiting the strict selectivity of Novozym 435 for the
minor b-epoxides components of epimeric mixtures.
This biotransformation not only confirms the selectivity
of this lipase, originally isolated from the yeast Candida
antarctica, but is also a new noteworthy example of
selectivity control by remote stereocentres.23
The screening of a library of commercially available
lipases also indicated that the enzyme from C. rugosa
lipase has an opposite selectivity compared to Novozym
435, thus allowing the isolation of diastereomerically
pure b-epoxides via alcoholysis reactions.
Finally, a mild and clean deacylation reaction of the 3b-
acetoxy group in the presence of the sensitive 5,6-epoxy
moiety was attained using C. rugosa lipase as catalyst
and water as nucleophile.4. Experimental
4.1. General
All commercially available chemicals were used as sup-
plied by the manufacturers. Steroids and crude C. rug-
osa lipase were from Sigma. Novozym 435 (immobilised
C. antarctica lipase B) and Lypozyme IM 20 were from
Novo Nordisk. Lipase PS (from Pseudomonas cepacia)
was purchased from Amano and adsorbed on Celite as
described elsewhere.24 Lipase AK (from Pseudomonas
fluorescens) and lipase AY (from C. rugosa) were from
Amano. C. viscosum lipase was supplied by Finnsugar.
1H NMR and 13C NMR spectra were recorded on a
Bruker AC-300 at 300 and 75.47MHz, respectively,
using CDCl3 as a solvent. Chemical shifts are reported
on the d (ppm) scale and are relative to tetramethylsilane
as the internal standard. Infrared spectra were recorded
on a Jasco FT/IR-420 spectrometer. Optical rotations
were determined on a Jasco P-1020 polarimeter. Melting
points were measured in a B€uchi B-540. TLC monitor-
ing was done in toluene/diethyl ether (85:15) as eluent,
and detected using Komarowskys reagent.25 Thedegrees of conversion were determined by gas chroma-
tography using a Hewlett Packard 5890 series II
instrument, a HP-1 Crosslinked Methyl Silicone Gum
(25m, 0.32mm ID, Hewlett Packard), oven tempera-
tures ranging from 236 to 290 C and H2 as the carrier
gas.4.2. Chemical synthesis of 5a,6a- and 5b,6b-epoxysteroids
4.2.1. Representative procedure for the epoxidation of 3b-
hydroxy-D5 unsaturated steroids with MMPP. To a
solution of the 3b-hydroxy-D5-unsaturated steroid
(1mmol) in CH2Cl2 (10ml) and ethanol (2ml), magne-
sium monoperoxyphthalate hexahydrate (MMPP,
990mg, 2mmol) was added and the suspension stirred at
room temperature for 24 h. After this time the reaction
was shown to have gone to completion (TLC control).
Then, sodium chloride and diethyl ether were added and
the suspension filtered through Celite. The filtrate was
washed with 5% HCl, satd NaHCO3, water and brine,
dried over MgSO4 and evaporated to dryness, giving the
a-enriched epimeric mixtures of the epoxides as the only
products.
Compound 1: 1H NMR d: 0.61 (3H, s, CH3-18), 1.06
(3H, s, CH3-19), 2.91 and 3.07 (1H, d each, J ¼ 4:362
and 2.190Hz, respectively, H-6), 3.90 (1H, m, H-3). The
integration of the two signals (doublet peaks) due to the
H-6 proton gave a 8.3:1.7 a=b ratio. 13C NMR d: 59.33
(C-3), 65.77 (C-5), 68.70 (C-6). IR (ATR): mmax 1038.48,
1366.3, 1465.6, 2864.7, 2931.3, 3395 cm1.
Compound 2: 1H NMR d: 0.56 (3H, s, CH3-18), 1.00
(3H, s, CH3-19), 2.03 (3H, s, CH3-21), 2.92 and 3.08
(1H, d each, J ¼ 4:359 and 2.352Hz, respectively, H-6),
3.90 (1H, m, H-3). The integration of the two signals
(doublet peaks) due to the H-6 proton gave a 9:1 a=b
ratio. 13C NMR d: 59.06 (C-3), 63.33 (C-17), 65.67
(C-5), 68.58 (C-6), 209.52 (C-20). IR (ATR): mmax 1049.1,
1355, 1684, 1700.9, 2930.3, 3437.5 cm1.
Compound 3: 1 H NMR d: 0.82 (3H, s, CH3-18), 1.09
(3H, s, CH3-19), 2.95 and 3.13 (1H, d each, J ¼ 4:329
and 2.532Hz, respectively, H-6), 3.90 (1H, m, H-3). The
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H-6 proton gave a 9:1 a=b ratio. 13C NMR d: 58.75 (C-
3), 65.72 (C-5), 68.49 (C-6), 220.68 (C-17). IR (ATR):
mmax 1027.9, 1725.0, 2944.8, 3518 cm1.4.2.2. Representative procedure for the epoxidation of 3b-
acetoxy-D5-unsaturated steroids with KMnO4/inorganic
salts. To a solution of the 3b-acetoxy-D5-unsaturated
steroid (1mmol) in CH2Cl2 (5ml), a mixture of finely
powdered KMnO4 (350mg) and Fe2(SO4)3(H2O)n
(175mg) was added. Then, water (75 ll) and t-butyl
alcohol (0.5ml) were added and the reaction mixture left
overnight at room temperature under magnetic stirring.
After this time the reaction was shown to have gone to
completion (TLC control). Sodium chloride and diethyl
ether were added and the suspension was filtered
through Celite. The filtrate was evaporated to dryness,
giving the b-enriched epimeric mixtures of the epoxides
as the only products.
Compound 4: 1 H NMR d: 0.64 (3H, s, CH3-18), 1.00
(3H, s, CH3-19), 2.03 (3H, s, CH3CO), 2.90 and 3.08
(1H, d each, J ¼ 4:371 and 1.941Hz, respectively, H-6),
4.77 (1H, m, H-3). The integration of the two signals
(doublet peaks) due to the H-6 proton gave a 1.1:8.9 a=b
ratio. 13C NMR d: 59.14 (C-6), 65.15 (C-5), 71.36 (C-3),
170.21 (CH3CO). IR (ATR): mmax 1030.8, 1243.9, 1363.4,
1465.6, 1731.8, 2866.7, 2933.2 cm1.
Compound 5: 1H NMR d: 0.59 (3H, s, CH3-18), 1.01
(3H, s, CH3-19), 2.03 (3H, s, CH3CO), 2.11 (3H, s, CH3-
21), 2.91 and 3.09 (1H, d each, J ¼ 4:347 and 2.163Hz,
respectively, H-6), 4.77 (1H, m, H-3). The integration of
the two signals (doublet peaks) due to the H-6 proton
gave a 1.3:8.7 a=b ratio. 13C NMR d: 62.42 (C-5), 63.35
(C-17), 63.60 (C-6), 71.19 (C-3), 170.55 (CH3CO),
209.37 (C-20). IR (ATR): mmax 1029.8, 1243.9, 1356.7,
1698.9, 1735, 2930.0 cm1.
Compound 6: 1H NMR d: 0.85 (3H, s, CH3-18), 1.04
(3H, s, CH3-19), 2.04 (3H, s, CH3CO), 2.94 and 3.15
(1H, d each, J ¼ 4:341 and 2.493Hz, respectively, H-6),
4.77 (1H, m, H-3). The integration of the two signals
(doublet peaks) due to the H-6 proton gave a 0.9:9.1 a=b
ratio. 13C NMR d: 62.56 (C-5), 63.17 (C-6), 71.10 (C-3),
170.53 (CH3CO), 220.77 (C-17). IR (ATR): mmax 1029.8,
1240.0, 1727.9, 2946.7 cm1.4.3. Enzymatic acylation of 3b-hydroxy-5,6-epoxysteroids
In a typical screening assay, 3b-hydroxy-5a,6a-epoxy- or
3b-hydroxy-5b,6b-epoxy-steroid (10mg) dissolved in tol-
uene (0.9ml) and vinyl acetate (0.1ml) was added to the
enzyme (50mg of crude enzymes, 10mg of Lypozyme IM
20 or 10mg of Novozym 435) in 3ml vials. The vials were
stopped with a cap and shaken at 250 rpm at 45 C. The
reactions were monitored by TLC and GC (see Table 1).4.3.1. 5a,6a-Epoxycholestan-3b-ol, 1a. To a solution of
5,6-epoxycholestan-3b-ol 1 (150mg, a=b ratio 8.3:1.7) intoluene (8.5ml) and vinyl acetate (1.5ml), Novozym 435
(75mg) was added and the reaction shaken at 45 C.
After 24 h the enzyme was filtered off and the solvent
evaporated. 5a,6a-Epoxycholestan-3b-ol 1a (100mg,
67% yield) was isolated by flash chromatography
(petroleum ether/ethyl acetate 1:1) as a single diaste-
reomer ½a21D ¼ 44:5, (c 0.5, CHCl3) {lit.26 ½aD ¼ 47},
mp 141.5–142.7 C (lit.26 141–142 C) as indicated by 1H
NMR.4.3.2. 5a,6a-Epoxy-3b-hydroxypregnan-20-one, 2a. To a
solution of 5,6-epoxy-3b-hydroxypregnan-20-one 2 (150
mg, a=b ratio 9.1:0.9) in toluene (8.5ml) and vinyl ace-
tate (1.5ml), Novozym 435 (75mg) was added and the
reaction shaken at 45 C. After 24 h the enzyme was
filtered off and the solvent evaporated. 5a, 6a-epoxy-3b-
hydroxypregnan-20-one 2a (108 mg, 72% yield) was
isolated by flash chromatography (petroleum ether,
ethyl acetate 1:1) as a single diastereomer ½a21D ¼ þ6:35,
(c 0.84, CHCl3) {lit.27 ½aD ¼ þ1}, mp 179.2–182.0 C
(lit.27 190–191 C), as indicated by 1H NMR.4.3.3. 5a,6a-Epoxy-3b-hydroxyandrostan-17- one, 3a. To
a solution of 5,6-epoxy-3b-hydroxyandrostan-17-one (3,
150mg a=b ratio 9:1) in toluene (8.5ml) and vinyl ace-
tate (1.5ml), Novozym 435 (75mg) was added and the
reaction was shaken at 45 C. After 24 h the enzyme was
filtered off and the solvent was evaporated. 5a,6a-
Epoxy-3b-hydroxyandrostan-17-one (3a, 103mg, 69%
yield) was isolated by flash chromatography (petroleum
ether/ethyl acetate 1:1.5) as a single diastereomer
{½a21D ¼ 4:3, c 0.5, CHCl3, mp 225–228 C (lit.9b 227–
230 C)}, as indicated by 1H NMR.4.4. Enzymatic deacylation of 3b-acetoxy-5a,6a- and
5b,6b-epoxysteroids
In a typical screening assay, the 3b-acetoxy-5a,6a-
epoxy- or 3b-acetoxy-5b,6b-epoxy-steroid (10mg) hav-
ing been dissolved in toluene (0.9ml) and octanol
(0.1ml), were added to the enzyme (50mg of crude
enzymes, 10mg of Lypozyme IM 20 or 10mg of Nov-
ozym 435) in 3ml vials. The vials were stopped with a
cap and shaken at 250 rpm at 45 C. The reactions were
monitored by TLC over 5 days.4.4.1. 5b,6b-Epoxycholestan-3b-yl acetate, 10b. To a
solution of 5,6-epoxycholestan-3b-yl acetate 4 (180mg,
a=b ratio 1.1:8.9) in toluene (8ml) and octanol (2ml),
lipase AY (200mg) was added and the reaction shaken
at 45 C. After 3 days, the enzyme was filtered off and
solvent was evaporated. 5b,6b-Epoxycholestan-3b-yl
acetate 10b (112mg, 62% yield) was isolated by flash
chromatography (petroleum ether/ethyl acetate 2:1) as a
single diastereomer ½a21D ¼ 0:57, (c 1.09, CHCl3) {lit.28½aD ¼ 0:2}, mp 109–111 C (lit.28 112–113 C), as
indicated by 1H NMR.
1178 M. M. Cruz Silva et al. / Tetrahedron: Asymmetry 15 (2004) 1173–11794.4.2. 5b,6b-Epoxy-20-oxo-pregnan-3b-yl acetate, 20b. To
a solution of 5,6-epoxy-20-oxo-pregnan-3b-yl acetate 5,
(180mg, a=b ratio 1.3:8.7) in toluene (8ml) and octanol
(2ml), lipase AY (200mg) was added and the reaction
shaken at 45 C. After 3 days, the enzyme was filtered off
and the solvent was evaporated. 5b,6b-Epoxy-20-oxo-
pregnan-3b-yl acetate 20b (126mg, 70% yield) was isol-
ated by flash chromatography (petroleum ether/ethyl
acetate 2:1) as a single diastereomer. ½a21D ¼ þ50:6, (c
1.18, CHCl3) {lit.
8a ½aD ¼ þ50}, mp 132–134 C (lit.8a
132–136 C), as indicated by 1H NMR.4.4.3. 5b,6b-Epoxy-17-oxo-androstan-3b-yl acetate, 30b.
To a solution of 5,6-epoxy-17-oxo-androstan-3b-yl
acetate 6 (180mg, a=b ratio 1:9) in toluene (8ml) and
octanol (2ml), lipase AY (200mg) was added and the
reaction shaken at 45 C. After 3 days, the enzyme was
filtered off and the solvent evaporated. 5b,6b-Epoxy-17-
oxo-androstan-3b-yl acetate 30b (135mg, 75% yield) was
isolated by flash chromatography (petroleum ether/ethyl
acetate 1:1) as a single diastereomer, ½a21D ¼ þ43:0, (c
1.4, CHCl3) {lit.
29 ½aD ¼ þ40:5}, mp 186.7–188 C (lit.29
185–187 C), as indicated by 1H NMR.4.5. Total hydrolysis of 3b-acetoxy-5a,6a- and 5b,6b-
epoxysteroids
In a typical experiment, the 3b-acetoxy-5,6-epoxysteroid
(150mg), obtained by permanganate epoxidation, was
dissolved in diisopropyl ether (35ml) presaturated with
water and then C. rugosa lipase (1.8 g) added. The
mixture was shaken at 250 rpm, 45 C and after 3 days
the reactions were shown to have gone to completion.
The products were isolated and the a=b ratios quantified
by 1H NMR: 5,6-epoxycholestan-3b-ol 7 (136mg, a=b
ratio 1:9), 5,6-epoxy-3b-hydroxypregnan-20-one 8
(130mg, a=b ratio 1.2:8.8) and 5,6-epoxy-3b-hydroxy-
androstan-17-one 9 (135mg, a=b ratio 0.9:9.1).
4.6. 5b,6b-Epoxycholestan-3b-ol 1b
To a solution of 5,6-epoxycholestan-3b-ol 7 (136mg, a=b
ratio 1:9) in toluene (6ml) and vinyl acetate (1ml), Lipase
AY (100mg) was added and the reaction shaken at 45 C.
After 3 days the enzyme was filtered off and the solvent
evaporated. 5b,6b-Epoxycholestan-3b-ol 1b (100.5mg,
74% yield) was isolated by flash chromatography
(petroleum ether/ethyl acetate 1:1) as a single diastereo-
mer, ½a21D ¼ þ8:0, (c 0.5, CHCl3) {lit.29 ½aD ¼ þ7:8}, mp
127–129 C (lit.29 128–131 C), as indicated by 1H NMR.Acknowledgements
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